TUMOR-TREATING-FIELD (TTFIELD) EFFECTS ON GLIOBLASTOMA CELLS ARE AUGMENTED BY MITOTIC CHECKPOINT INHIBITION

被引：0
|
作者：
Kessler, Almuth F. [1 ]
Froembling, Greta Eliza [1 ]
Gross, Franziska [1 ]
Ernestus, Ralf-Ingo [1 ]
Loehr, Mario [1 ]
Hagemann, Carsten [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Neurosurg, Tumorbiol Lab, Wurzburg, Germany
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-07
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] Combination Treatment of Irradiation and Tumor Treating Fields for Human Glioblastoma Cells
    Stein, M.
    Beusker, P.
    Goett, H.
    Kolodziej, M.
    Uhl, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E600 - E600
  • [22] Inhibition of AURKA destabilizes glioblastoma primary cilia and sensitizes cells to tumor treating fields (TTFields) in vitro and ex vivo
    Tian, Jia
    Mallinger, Julianne
    Shi, Ping
    Ling, Dahao
    Deleyrolle, Loic
    Lin, Min
    Khoshbouei, Habibeh
    Sarkisian, Matthew
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint
    Kops, GJPL
    Foltz, DR
    Cleveland, DW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) : 8699 - 8704
  • [24] Investigating the Effects of Tumor Treating Fields and Genetic Mutations in Patients With Glioblastoma
    Wang, Andy
    Arkun, Knarik
    NEUROLOGY, 2023, 100 (17)
  • [25] Mitotic spindle checkpoint complex protects tumor cells from undergoing mitotic catastrophe after release from G1 checkpoint arrest
    Vivo, Claire
    Davis, Brian M.
    Roninson, Igor B.
    Broude, Eugenia V.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Synergistic effects of topical diphencyprone and immune checkpoint inhibition in treating cutaneous metastases
    Block, B. R.
    Piontkowski, A.
    Poplausky, D.
    Estrada, Y.
    Gour, D.
    Gulati, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S51 - S51
  • [27] Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience
    Ballo, Matthew T.
    Qualls, Kaitlin W.
    Michael, L. Madison
    Sorenson, Jeffrey M.
    Baughman, Brandon
    Karri-Wellikoff, Saradasri
    Pandey, Manjari
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [28] Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
    Jo, Yunhui
    Kim, Eun Ho
    Sai, Sei
    Kim, Jin Su
    Cho, Jae-Min
    Kim, Hyeongi
    Baek, Jeong-Hwa
    Kim, Jeong-Yub
    Hwang, Sang-Gu
    Yoon, Myonggeun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [29] EFFECTS OF CAFFEINE ON RADIATION-INDUCED MITOTIC INHIBITION IN S-180 ASCITES TUMOR-CELLS
    BOYNTON, AL
    EVANS, TC
    CROUSE, DA
    RADIATION RESEARCH, 1974, 60 (01) : 89 - 97
  • [30] z-LEUCINYL-LEUCINYL-NORLEUCINAL INDUCES APOPTOSIS OF HUMAN GLIOBLASTOMA TUMOR-INITIATING CELLS BY PROTEASOME INHIBITION AND MITOTIC ARREST RESPONSE
    Monticone, M.
    Biollo, E.
    Fabbi, M.
    Daga, A.
    Romeo, F.
    Maffei, M.
    Melotti, A.
    Giaretti, W.
    Corte, G.
    Castagnola, P.
    CELLULAR ONCOLOGY, 2010, 32 (03) : 234 - 235
12345